While our data did not confirm the association between TRAP1 and lymph node metastasis, they provide clear evidence that TRAP1 client protein network may be regarded as prognostic biomarker to drive clinical decisions in metastatic setting, even though several issues still needs to be addressed/confirmed in this perspective. Here, TRAP1 is linked to metastatic malignant neoplasm in the lymph nodes.